niaprazine,
niaprazine trihydrochloride,
Nopron,
Niaprazine,
Nopron,
27367-90-4,
Niaprazine [INN:DCF],
1709 CERM,
Niaprazinum [INN-Latin],
Niaprazina [INN-Spanish],
EINECS 248-431-5,
BRN 0844157,
UNII-5QKW305N9F,
5QKW305N9F,
C20H25FN4O,
UNII-1346Q758L9,
1346Q758L9,
N-(3-(4-(p-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)nicotinamide,
N-(3-(4-(4-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)-3-pyridinecarboxamide,
Niaprazina,
Niaprazinum,
N-(4-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)BUTAN-2-YL)NICOTINAMIDE,
Nicotinamide, N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-,
Niaprazine (INN),
Nopron (TN),
Niaprazine, (+)-,
Niaprazine, (-)-,
AC1L2H2D,
SCHEMBL352977,
CHEMBL2105141,
CHEBI:135505,
AKOS022185020,
LS-96431,
FT-0687290,
D07333,
N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide,
3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-,
3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)- (9CI),
3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (+)-,
3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (-)-,
N-(3-(4-(4-fluorophenyl)-1-piperazinyl)- 1-methylpropyl)-3-pyridinecarboxamide,
119306-37-5,
119328-74-4,
UNII-R2H3YN6E3L,
Niaprazine [DCF:INN],
Niaprazine trihydrochloride,
R2H3YN6E3L,
CID71919,
C20-H25-F-N4-O,
5-23-01-00362 (Beilstein Handbook Reference),
N-[3-[4-(p-fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide,
Nicotinamide, N-[3-[4-(p-fluorophenyl)-1-piperazinyl]-1-methylpropyl]-,
3-Pyridinecarboxamide, N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1-methylpropyl]-,
N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]-3-pyridinecarboxamide,